Nurix Therapeutics (NRIX) Stock Forecast & Price Target

→ Historic NVIDIA partnership could send this tiny AI stock soaring... (From Behind the Markets) (Ad)

$18.44

+3.15 (+20.60%)

(As of 06/18/2024 ET)

Nurix Therapeutics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 10 Analyst Ratings

Consensus Price Target

$24.80
34.49% Upside

High Forecast	$35.00
Average Forecast	$24.80
Low Forecast	$10.00

Type	Current Forecast 6/20/23 to 6/19/24	1 Month Ago 5/21/23 to 5/20/24	3 Months Ago 3/22/23 to 3/21/24	1 Year Ago 6/20/22 to 6/20/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	9 Buy rating(s)	7 Buy rating(s)	4 Buy rating(s)	9 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$24.80	$21.88	$20.40	$29.70
Forecasted Upside	34.49% Upside	62.38% Upside	100.91% Upside	163.41% Upside

Get Nurix Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NRIX and its competitors with MarketBeat's FREE daily newsletter.

Ad Behind the Markets

Historic NVIDIA partnership could send this tiny AI stock soaring...

After striking partnerships with trillion-dollar chipmaker NVIDIA... ARM surged over 60% in a week... Who's next?

Click here to discover the name and ticker symbol >>>

NRIX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

NRIX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Nurix Therapeutics Stock vs. The Competition

Type	Nurix Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	2.90	2.70	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	34.49% Upside	1,068.17% Upside	11.30% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
6/18/2024	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$19.00 ➝ $26.00	+70.05%
6/17/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$30.00 ➝ $31.00	+106.12%
6/17/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$31.00 ➝ $31.00	+104.22%
6/5/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$35.00 ➝ $35.00	+113.94%
5/15/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$27.00	+80.60%
5/14/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Loganathan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$20.00	+43.47%
Get the Latest News and Ratings for NRIX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Nurix Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
4/11/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$22.00 ➝ $23.00	+33.95%
4/11/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$24.00 ➝ $25.00	+59.34%
2/26/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$9.00 ➝ $10.00	-11.35%
2/16/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$23.00 ➝ $20.00	+100.80%
3/9/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$20.00	+120.99%
2/27/2023	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$25.00	+178.40%
12/13/2022	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$37.00 ➝ $28.00	+126.72%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 06:09 AM ET.

NRIX Forecast - Frequently Asked Questions

What is Nurix Therapeutics's stock forecast and purchase recommendation?: According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Nurix Therapeutics is $24.80, with a high forecast of $35.00 and a low forecast of $10.00. The consensus rating for Nurix Therapeutics stock is Moderate Buy based on the current 1 hold rating and 9 buy ratings for NRIX. Learn more on NRIX's analyst rating history.
Do Wall Street analysts like Nurix Therapeutics more than its competitors?: Analysts like Nurix Therapeutics more than other "medical" companies. The consensus rating score for Nurix Therapeutics is 2.90 while the average consensus rating score for "medical" companies is 2.70. Learn more on how NRIX compares to other companies.
Does Nurix Therapeutics's stock price have much upside?: According to analysts, Nurix Therapeutics's stock has a predicted upside of 71.20% based on their 12-month stock forecasts.